Hypersomnia due to other mental disorder
Methodology & AI Transparency ⓘ
Hypersomnia due to other mental disorder Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Physicians managing Hypersomnia due to other mental disorder (F51.13; Insomnia, Sleep Apnea & Sleep Health) utilize iron/thyroid screening [Hypersomnia due to other mental disorder F51.13] and objective Nocturnal Oxygen Saturation in Hypersomnia due to other mental disorder (F51.13: (SpO2)) targets (>= 94% nadir > 90% (F51.13)) to prevent progression and functional morbidity.
- 2 Real-world patient consensus: Mapped to Insomnia, Sleep Apnea & Sleep Health under ICD-10-CM F51.13 for Hypersomnia due to other mental disorder clinical workups.
- 3 Typical cash cost range: Clinicians assessing Hypersomnia due to other mental disorder focus on or upper-airway pharyngeal in Hypersomnia due to other mental disorder (F51.13: collapse during REM) and targeted history.
- 4 Top reported side effects / signs: Longitudinal Hypersomnia due to other mental disorder monitoring tracks Nocturnal Oxygen Saturation in Hypersomnia due to other mental disorder (F51.13: (SpO2)) toward >= 94% nadir > 90% (F51.13).
Ask our AI Specialists anything about Hypersomnia due to other mental disorder
What Is Hypersomnia due to other mental disorder?
Physicians managing Hypersomnia due to other mental disorder (F51.13; Insomnia, Sleep Apnea & Sleep Health) utilize iron/thyroid screening [Hypersomnia due to other mental disorder F51.13] and objective Nocturnal Oxygen Saturation in Hypersomnia due to other mental disorder (F51.13: (SpO2)) targets (>= 94% nadir > 90% (F51.13)) to prevent progression and functional morbidity.
Pathophysiology, Underlying Causes & Clinical Presentation
In Hypersomnia due to other mental disorder (F51.13), physiological disruption stems from or upper-airway pharyngeal in Hypersomnia due to other mental disorder (F51.13: collapse during REM), informing Insomnia, Sleep Apnea & Sleep Health protocols that track Serum Ferritin (Restless in Hypersomnia due to other mental disorder (F51.13: Legs)) (> 75 ng/mL (F51.13)).
Common Symptoms & Clinical Signs
- • Presentation of Hypersomnia due to other mental disorder (F51.13): loud habitual snoring, in Hypersomnia due to other mental disorder (F51.13: witnessed breathing pauses,)
- • Secondary Hypersomnia due to other mental disorder clinical sign: daytime microsleeps, cognitive in Hypersomnia due to other mental disorder (F51.13: brain fog, or)
- • Symptom flares in Hypersomnia due to other mental disorder correlating with Nocturnal Oxygen Saturation in Hypersomnia due to other mental disorder (F51.13: (SpO2)) deviation outside >= 94% nadir > 90% (F51.13)
- • Functional sleep disorders impact requiring iron/thyroid screening [Hypersomnia due to other mental disorder F51.13] evaluation (F51.13)
Hypersomnia due to other mental disorder Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F51.13 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Insomnia, Sleep Apnea & Sleep Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Nocturnal Oxygen Saturation in Hypersomnia due to other mental disorder (F51.13: (SpO2)) | >= 94% nadir > 90% (F51.13) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Ferritin (Restless in Hypersomnia due to other mental disorder (F51.13: Legs)) | > 75 ng/mL (F51.13) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Apnea-Hypopnea Index (AHI) [Hypersomnia due to other mental disorder F51.13] | < 5 events/hour (F51.13) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Hypersomnia due to other mental disorder
Treatment selection for Hypersomnia due to other mental disorder depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Hypersomnia due to other mental disorder)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Is adenotonsillectomy effective in improving central apnea events in patients: What a 1,287-Participant Study Found Adenotonsillectomy improves central apnea events in patients with OSA but not in those with comorbidities. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery • 2023-12-15 • Meta-Analysis | N = 1,287 | 94/100 | PMID 37642712 ↗ |
| Can This Approach Help? Inside the Latest Research on Smartphone-Based Real-Time Assessment of Daytime trouble sleeping Symptoms With Participants included 40 older adults (mean [SD] age, 67.9 [5.4] years; 36 [90%] women), with 20 participants randomized to suvorexant and 20 to placebo. JAMA network open • 2026-01-02 • Randomized Controlled Trial | N = 40 | 88/100 | PMID 41490112 ↗ |
| Can This Approach Help? Inside the Latest Research on A minimal clinically important difference for the sleep inertia visual analog Establishing an MCID strengthens the SI-VAS value, adds context for findings related to sleep inertia in individuals with idiopathic hypersomnia from the phase 3 study, and aids clinicians in identifying clinically meaningful... Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine • 2025-07-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40135693 ↗ |
| Managing Trouble sleeping: Can Medicinal cannabis improves sleep Make a Real Difference? (What New Research Reveals) Observed effects were more pronounced in Phase 2 due to the period effect and loss of blinding. Journal of sleep research • 2023-06-15 • Randomized Controlled Trial | N = 29 | 88/100 | PMID 36539991 ↗ |
| Can This Approach Help? Inside the Latest Research on Low-sodium oxybate on diary-based sleep time in a clinical study in adults with Open-label LXB treatment in adults with idiopathic hypersomnia was associated with reductions in 24-hour TST, nocturnal TST, and total nap duration. Sleep medicine • 2026-02-15 • Phase III Randomized Trial | N = 148 | 88/100 | PMID 41442817 ↗ |
Hypersomnia due to other mental disorder Patient Community & “People Like Me” Threads
Filter Hypersomnia due to other mental disorder community threads and patient logs by age, biological sex, dosage, and treatment duration.